150 related articles for article (PubMed ID: 19895863)
1. Nanoparticle-integrin antagonist C16Y peptide treatment of choroidal neovascularization in rats.
Kim H; Csaky KG
J Control Release; 2010 Mar; 142(2):286-93. PubMed ID: 19895863
[TBL] [Abstract][Full Text] [Related]
2. Anti-VEGF PolysiRNA Polyplex for the Treatment of Choroidal Neovascularization.
Lee J; Ryoo NK; Han H; Hong HK; Park JY; Park SJ; Kim YK; Sim C; Kim K; Woo SJ; Park KH; Kim H
Mol Pharm; 2016 Jun; 13(6):1988-95. PubMed ID: 27173745
[TBL] [Abstract][Full Text] [Related]
3. Long-term suppression of ocular neovascularization by intraocular injection of biodegradable polymeric particles containing a serpin-derived peptide.
Shmueli RB; Ohnaka M; Miki A; Pandey NB; Lima e Silva R; Koskimaki JE; Kim J; Popel AS; Campochiaro PA; Green JJ
Biomaterials; 2013 Oct; 34(30):7544-51. PubMed ID: 23849876
[TBL] [Abstract][Full Text] [Related]
4. Fenofibrate-Loaded Biodegradable Nanoparticles for the Treatment of Experimental Diabetic Retinopathy and Neovascular Age-Related Macular Degeneration.
Qiu F; Meng T; Chen Q; Zhou K; Shao Y; Matlock G; Ma X; Wu W; Du Y; Wang X; Deng G; Ma JX; Xu Q
Mol Pharm; 2019 May; 16(5):1958-1970. PubMed ID: 30912953
[TBL] [Abstract][Full Text] [Related]
5. Topical ocular delivery to laser-induced choroidal neovascularization by dual internalizing RGD and TAT peptide-modified nanoparticles.
Chu Y; Chen N; Yu H; Mu H; He B; Hua H; Wang A; Sun K
Int J Nanomedicine; 2017; 12():1353-1368. PubMed ID: 28260884
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Experimental Choroidal Neovascularization by a Novel Peptide Derived from Calreticulin Anti-Angiogenic Domain.
Bee YS; Ma YL; Chen J; Tsai PJ; Sheu SJ; Lin HC; Huang H; Liu GS; Tai MH
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30274378
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of choroidal neovascularization by intravitreal ketorolac.
Kim SJ; Toma HS
Arch Ophthalmol; 2010 May; 128(5):596-600. PubMed ID: 20457981
[TBL] [Abstract][Full Text] [Related]
8. [Inhibitory effect of RGDS peptide on experimental choroidal neovascularization in a rat model].
He H; Zhang H; Wang ZT; Zhao CM; Xiang N
Zhonghua Yan Ke Za Zhi; 2006 Sep; 42(9):825-31. PubMed ID: 17173745
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory efficacy of intravitreal dexamethasone acetate-loaded PLGA nanoparticles on choroidal neovascularization in a laser-induced rat model.
Xu J; Wang Y; Li Y; Yang X; Zhang P; Hou H; Shi Y; Song C
J Ocul Pharmacol Ther; 2007 Dec; 23(6):527-40. PubMed ID: 18001232
[TBL] [Abstract][Full Text] [Related]
10. Intravenous treatment of choroidal neovascularization by photo-targeted nanoparticles.
Wang Y; Liu CH; Ji T; Mehta M; Wang W; Marino E; Chen J; Kohane DS
Nat Commun; 2019 Feb; 10(1):804. PubMed ID: 30778060
[TBL] [Abstract][Full Text] [Related]
11. Baicalin attenuates laser-induced choroidal neovascularization.
Yang SJ; Jo H; Kim JG; Jung SH
Curr Eye Res; 2014 Jul; 39(7):745-51. PubMed ID: 24502359
[TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory and antiangiogenic effects of nanoparticle-mediated delivery of a natural angiogenic inhibitor.
Jin J; Zhou KK; Park K; Hu Y; Xu X; Zheng Z; Tyagi P; Kompella UB; Ma JX
Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6230-7. PubMed ID: 21357401
[TBL] [Abstract][Full Text] [Related]
13. Modification of the C16Y peptide on nanoparticles is an effective approach to target endothelial and cancer cells via the integrin receptor.
Hamano N; Negishi Y; Fujisawa A; Manandhar M; Sato H; Katagiri F; Nomizu M; Aramaki Y
Int J Pharm; 2012 May; 428(1-2):114-7. PubMed ID: 22421321
[TBL] [Abstract][Full Text] [Related]
14. Angiogenesis inhibition and choroidal neovascularization suppression by sustained delivery of an integrin antagonist, EMD478761.
Fu Y; Ponce ML; Thill M; Yuan P; Wang NS; Csaky KG
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5184-90. PubMed ID: 17962472
[TBL] [Abstract][Full Text] [Related]
15. Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration.
Chan CK; Meyer CH; Gross JG; Abraham P; Nuthi AS; Kokame GT; Lin SG; Rauser ME; Kaiser PK
Retina; 2007 Jun; 27(5):541-51. PubMed ID: 17558314
[TBL] [Abstract][Full Text] [Related]
16. [Novel approach for management of age-related macular degeneration--antiangiogenic therapy and retinal regenerative therapy].
Tamaki Y
Nippon Ganka Gakkai Zasshi; 2007 Mar; 111(3):232-68; discussion 269. PubMed ID: 17402564
[TBL] [Abstract][Full Text] [Related]
17. RETRACTED: Influence of choroidal neovascularization and biodegradable polymeric particle size on transscleral sustained delivery of triamcinolone acetonide.
Kadam RS; Tyagi P; Edelhauser HF; Kompella UB
Int J Pharm; 2012 Sep; 434(1-2):140-7. PubMed ID: 22633904
[TBL] [Abstract][Full Text] [Related]
18. Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration.
Augustin AJ; Schmidt-Erfurth U
Ophthalmology; 2006 Jan; 113(1):14-22. PubMed ID: 16360209
[TBL] [Abstract][Full Text] [Related]
19. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.
Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441
[TBL] [Abstract][Full Text] [Related]
20. Subretinal transplantation of retinal pigment epithelium overexpressing fibulin-5 inhibits laser-induced choroidal neovascularization in rats.
Li F; Zeng Y; Xu H; Yin ZQ
Exp Eye Res; 2015 Jul; 136():78-85. PubMed ID: 25983185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
